Target intelligence / Profile preview

Surfactant protein A and Surfactant protein D (SP-A and SP-D)

Target
SP-A and SP-D
Molecular classification
Collectin family, C-type (calcium-dependent) lectins, Pattern recognition innate immune proteins, soluble glycoproteins
01

Overview

Surfactant protein A (SP-A) and surfactant protein D (SP-D) are large, hydrophilic, multidomain glycoproteins of the collectin family, characterized by collagen-like regions and C-type lectin carbohydrate recognition domains. They are primarily produced by alveolar type II epithelial cells in the lung and are also found on other mucosal surfaces. Their critical function is as pattern recognition molecules in the innate immune system: they bind carbohydrates and lipids on pathogen surfaces in a calcium-dependent manner, leading to aggregation, neutralization, and enhanced clearance by phagocytes. Both SP-A and SP-D regulate inflammation—dampening excessive responses under basal conditions but supporting pro-inflammatory pathways when pathogen burden is high. They are essential for pulmonary homeostasis and protection against infection, with roles in both lung and extrapulmonary immune defense. Recombinant versions are in development as potential therapies for respiratory infections and inflammatory lung diseases[1][2][3][5][6].

Other names
Pulmonary collectinsCollectinsCollagen-containing C-type lectinsSurfactant-associated protein A (for SP-A)Surfactant-associated protein D (for SP-D)
02

Mechanism of action

Pathogen binding via specific recognition of carbohydrate and lipid moieties on microbial surfaces; Opsonization, facilitating clearance by phagocytes; Direct agglutination and neutralization of pathogens (reducing infectivity and enhancing clearance); Immunomodulation, including downregulation of excess inflammation and modulation of macrophage and neutrophil function[1][3][5][6].

03

Biological functions

Pathogen recognition and bindingOpsonization and clearance of bacteria, fungi, and virusesModulation of inflammation and immune responseRegulation of surfactant homeostasisAgglutination of pathogensControlling alveolar macrophage activationRegulation of allergic responsesApoptotic cell clearancemaintenance of pulmonary homeostasis
04

Disease associations

Infection (bacterial, viral, fungal)InflammationLung injury and acute respiratory distress syndrome (ARDS)Neonatal chronic lung diseaseAllergic disease (e.g., asthma)immune-mediated lung diseases
05

Safety considerations

Immunogenicity of recombinant proteins (potential for anti-drug antibody formation)Theoretical risk: excessive immune suppression or enhancement if mistargetedLimited systemic exposure expected with localized (inhaled) administrationNo major toxicity reported in preclinical models, but clinical data are limited[1][6].
06

Interacting drugs

Recombinant human SP-A

1 more in the full profile.

07

Biomarkers

Reduced levels of SP-A and SP-D in bronchoalveolar lavage fluid or serum as indicators of increased susceptibility to lung infection and poor outcomes in acute lung injuryPolymorphisms in SFTPA and SFTPD genes as biomarkers of disease risk (e.g., infection susceptibility, chronic lung disease)[4].

Beyond the preview

Go deeper on Surfactant protein A and Surfactant protein D (SP-A and SP-D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surfactant protein A and Surfactant protein D (SP-A and SP-D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call